Following this week's elections, CFOs are again in the dark about the outlook for the cost, delivery, and quality of company-sponsored health care.
Health-care companies are a casualty of the cross purposes of the Affordable Care Act and antitrust laws.
MIT professor Jonathan Gruber, who helped write both the Affordable Care Act and the Massachusetts Health Connector, lays out the case for the law's impact.
An IRS compensation rule aimed at health insurers could actually apply to a wide range of companies.
